Accelerated ambulation after vascular access closure device
| Autor: | Sinan Sarsam, Marcel Zughaib, Daniel Brancheau, Mahmoud Assaad |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
Cardiac Catheterization Michigan medicine.medical_specialty Time Factors medicine.medical_treatment Vascular access Closure (topology) Hemorrhage Arteriotomy Punctures 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Catheterization Peripheral Early ambulation Humans Medicine Pharmacology (medical) Vascular closure device Prospective Studies 030212 general & internal medicine Early Ambulation Aged Original Research Aged 80 and over Hemostatic Techniques business.industry Equipment Design Middle Aged Surgery Femoral Artery Treatment Outcome Female Cardiology and Cardiovascular Medicine business Bed Rest Vascular Closure Devices |
| Zdroj: | Therapeutic Advances in Cardiovascular Disease. 12:141-144 |
| ISSN: | 1753-9455 1753-9447 |
| DOI: | 10.1177/1753944718756604 |
| Popis: | Background: Patients who are candidates to receive an Angioseal® (St. Jude Medical) device for arteriotomy closure are allowed to ambulate 20 min after the deployment of the device. More frequently, however, patients are kept on bed rest for several hours following Angioseal® deployment. The purpose of this study was to prospectively assess patients when ambulating 20 min after Angioseal® deployment instead of prolonged best rest of 2–3 h. Methods: Patients undergoing angiography from the common femoral artery approach were included in the study if they received a 6 Fr Angioseal® closure device. Results: Twenty-nine patients were successfully enrolled in the study; 27 (93.1%) patients ambulated at 20 min, 1 (3.45%) patient ambulated at 28 min, and 1 (3.45%) patient ambulated at 27 min due to transport times. There were zero complications with regard to hemorrhage or other groin complications. There is a substantial time difference in ambulation times between the conventional and early ambulation groups. Conclusion: Our study demonstrates that it is probably safe to ambulate patients who undergo diagnostic cardiac catheterization as early as 20 min after deployment of the 6 Fr Angioseal® closure device. ClinicalTrials.gov identifier: NCT03142126 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|